share_log

Retail Investors Invested in Winning Health Technology Group Co., Ltd. (SZSE:300253) Copped the Brunt of Last Week's CN¥408m Market Cap Decline

Retail Investors Invested in Winning Health Technology Group Co., Ltd. (SZSE:300253) Copped the Brunt of Last Week's CN¥408m Market Cap Decline

上週,深圳證券交易所上市公司衛寧健康(股票代碼300253)市值下跌了4.08億元,普通投資者成了最大的受害者。
Simply Wall St ·  06/28 19:42

Key Insights

  • The considerable ownership by retail investors in Winning Health Technology Group indicates that they collectively have a greater say in management and business strategy
  • A total of 25 investors have a majority stake in the company with 42% ownership
  • 23% of Winning Health Technology Group is held by insiders

If you want to know who really controls Winning Health Technology Group Co., Ltd. (SZSE:300253), then you'll have to look at the makeup of its share registry. With 56% stake, retail investors possess the maximum shares in the company. In other words, the group stands to gain the most (or lose the most) from their investment into the company.

While the holdings of retail investors took a hit after last week's 3.1% price drop, insiders with their 23% also suffered.

Let's delve deeper into each type of owner of Winning Health Technology Group, beginning with the chart below.

ownership-breakdown
SZSE:300253 Ownership Breakdown June 28th 2024

What Does The Institutional Ownership Tell Us About Winning Health Technology Group?

Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index.

As you can see, institutional investors have a fair amount of stake in Winning Health Technology Group. This implies the analysts working for those institutions have looked at the stock and they like it. But just like anyone else, they could be wrong. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of Winning Health Technology Group, (below). Of course, keep in mind that there are other factors to consider, too.

earnings-and-revenue-growth
SZSE:300253 Earnings and Revenue Growth June 28th 2024

Hedge funds don't have many shares in Winning Health Technology Group. The company's largest shareholder is Wei Zhou, with ownership of 11%. The second and third largest shareholders are Ying Wang and Shanghai Yunxin Venture Capital Co., Ltd., with an equal amount of shares to their name at 5.0%.

Our studies suggest that the top 25 shareholders collectively control less than half of the company's shares, meaning that the company's shares are widely disseminated and there is no dominant shareholder.

Researching institutional ownership is a good way to gauge and filter a stock's expected performance. The same can be achieved by studying analyst sentiments. Quite a few analysts cover the stock, so you could look into forecast growth quite easily.

Insider Ownership Of Winning Health Technology Group

While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO.

Most consider insider ownership a positive because it can indicate the board is well aligned with other shareholders. However, on some occasions too much power is concentrated within this group.

Our information suggests that insiders maintain a significant holding in Winning Health Technology Group Co., Ltd.. Insiders own CN¥2.9b worth of shares in the CN¥13b company. That's quite meaningful. Most would say this shows a good degree of alignment with shareholders, especially in a company of this size. You can click here to see if those insiders have been buying or selling.

General Public Ownership

The general public, who are usually individual investors, hold a substantial 56% stake in Winning Health Technology Group, suggesting it is a fairly popular stock. With this amount of ownership, retail investors can collectively play a role in decisions that affect shareholder returns, such as dividend policies and the appointment of directors. They can also exercise the power to vote on acquisitions or mergers that may not improve profitability.

Next Steps:

It's always worth thinking about the different groups who own shares in a company. But to understand Winning Health Technology Group better, we need to consider many other factors. Consider for instance, the ever-present spectre of investment risk. We've identified 1 warning sign with Winning Health Technology Group , and understanding them should be part of your investment process.

Ultimately the future is most important. You can access this free report on analyst forecasts for the company.

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論